Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Augusta, Baton Rouge, Bethlehem, Birmingham, Boston, Canton, Clermont, Coronado, Dallas, Evergreen Park, Gainesville, Hinsdale, Lancaster, Los Angeles, Mobile, Osage Beach, Philadelphia, Phoenix, Pittsburgh, Spokane, Tampa, Temple, Walnut Creek, White Plains
- Age
- 18 years to 130 years
- People
- 4,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - Phase 3Taking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Ann Arbor, Atlanta, Boston, Dallas, Detroit, Duarte, Greenville, Houston, Lone Tree, Louisville, Maple Grove, Morristown, Nashville, New Orleans, New York, Orlando, Portland, Richmond, Westwood
- Age
- 18 years and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - No phaseTaking peopleNovel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
- Where
- Englewood
- Age
- 18 years and over
- People
- 125
- Run by
- Englewood Hospital and Medical Center
See details and how to joinNCT06681818 - Phase 3Enrolling by invitationLong-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Where
- Bay Shore, Houston, Kettering, Memphis
- People
- 5,000
- Run by
- Exelixis
See details and how to joinNCT07620574 · EU 2026-525795-26-00 - Phase 1Taking peopleA Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Where
- Ann Arbor, Atlanta, Chicago, Cleveland, Dallas, Houston, Jacksonville, La Jolla, Los Angeles, New York, Phoenix, Pittsburgh, Richmond, Rochester, San Antonio
- Age
- 18 years and over
- People
- 158 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06600321 · EU 2024-519499-22-00 - Phase 2Taking peopleREGULUS: MRI-guided Adaptive SABR for Liver Cancers
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 62
- Run by
- Stanford University
See details and how to joinNCT07223307 - Phase 2Taking peopleCabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
- Where
- Orange
- Age
- 18 years and over
- People
- 35
- Run by
- University of California, Irvine
See details and how to joinNCT04472767 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1/2Taking peopleTesting the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
- Where
- Irvine, Orange, Pittsburgh, Portland
- Age
- 18 years and over
- People
- 92
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06811116 - Phase 1/2Taking peopleZanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 59
- Run by
- Devalingam Mahalingam
See details and how to joinNCT07042919 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- Where
- Chicago, Detroit, Duarte, Hackensack, Los Angeles, Mineola, Nashville, Portland, Seattle
- Age
- 18 years and over
- People
- 198 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07291076 · EU 2025-523602-33-00 - Phase 1Taking peopleA Phase 1 Study of the Safety and Tolerability of CTX-10726
- Where
- Greenville, Jacksonville, Lake Success, Nashville, Omaha, Phoenix, Pittsburgh, Rochester
- Age
- 18 years and over
- People
- 70
- Run by
- Compass Therapeutics
See details and how to joinNCT07419841 - Phase 2Taking peopleGemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- Where
- Basking Ridge, Bethesda, Commack, Durham, Harrison, Middletown, Montvale, New York, St Louis, Uniondale
- Age
- 18 years and over
- People
- 164 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04891289 · EU 2024-518065-10-00 - No phaseTaking peopleInterventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
- Where
- Durham
- Age
- 18 years and over
- People
- 78
- Run by
- Duke University
See details and how to joinNCT04933435 - Phase 1/2Taking peopleA Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
- Where
- Ann Arbor, Aurora, Baltimore, Birmingham, Cleveland, Dallas, Detroit, Houston, La Jolla, Los Angeles, McAllen, Milwaukee, New York, Oklahoma City, Orange, San Antonio, Seattle, Spokane, St Louis, Tampa, Washington D.C.
- Age
- 18 years and over
- People
- 193
- Run by
- Tvardi Therapeutics, Incorporated
See details and how to joinNCT05440708 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Austin, Canton, Celebration, Charleston, Cincinnati, Dallas, Dayton, Detroit, Fairfax, Greenville, Las Vegas, Los Angeles, Louisville, Margate, Nashville, New York, Orlando, Plantation, Saint Paul, Santa Monica, Spokane, Tamarac, Tucson
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 1Taking peopleA First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
- Where
- Dothan, Duarte, Nashville, Orlando
- Age
- 18 years and over
- People
- 148 worldwide
- Run by
- Bayer
See details and how to joinNCT06764316 · EU 2024-516615-25-00 - No phaseTaking peopleEUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
- Where
- Orlando
- Age
- 18 years to 100 years
- People
- 140
- Run by
- Orlando Health, Inc.
See details and how to joinNCT06340620 - Phase 1Taking peopleSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Where
- Atlanta, Denver, Los Angeles, Milwaukee, Newport, New York, Rochester, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Nammi Therapeutics Inc
See details and how to joinNCT06582017 - Phase 2Taking people[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
- Where
- Seattle
- Age
- 18 years and over
- People
- 22
- Run by
- University of Washington
See details and how to joinNCT07673341 - No phaseTaking peopleHistotripsy in Biliary Tract Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 24
- Run by
- NYU Langone Health
See details and how to joinNCT07853690 - Phase 2Taking peopleEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
- Where
- Cleveland, Columbus, Dallas, Santa Monica, Tampa
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Delcath Systems Inc.
See details and how to joinNCT06875128 · EU 2025-521966-91-00 - Phase 1/2Taking peopleEvaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
- Where
- Bethesda
- Age
- 18 years and over
- People
- 31
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04645160 - No phaseTaking peopleFrequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Where
- Columbus
- People
- 500
- Run by
- Mohamed Abdel-Rahman
See details and how to joinNCT04792463 - Phase 2Taking peoplePDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05286814